Cargando…
Benefits of using heterologous polyclonal antibodies and potential applications to new and undertreated infectious pathogens
BACKGROUND: Passive immunotherapy using polyclonal antibodies (immunoglobulins) has been used for over a century in the treatment and post-exposure prophylaxis of various infections and toxins. Heterologous polyclonal antibodies are obtained from animals hyperimmunised with a pathogen or toxin. AIMS...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Ltd.
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131169/ https://www.ncbi.nlm.nih.gov/pubmed/26802604 http://dx.doi.org/10.1016/j.vaccine.2016.01.016 |